CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
MINNEAPOLIS, Dec. 27, 2023 (GLOBE NEWSWIRE) — CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024. The Company is scheduled to present at 3:45pm Pacific Time the same day via webcast.
Related news for (CVRX)
- CVRx Announces Positive News on Outpatient Payment for Barostim
- 24/7 Market News Snapshot 16 July, 2025 – CVRx, Inc. Common Stock (NASDAQ:CVRX)
- CVRx Reports Preliminary First Quarter 2025 Financial Results
- CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2024 Financial Results and Issues Fiscal 2025 Guidance
- CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025